对2027年全球外周动脉疾病治疗药物市场的洞察-包括阿斯利康、赛诺菲和TheraVasc等公司-Research andMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peripheral Arterial Disease (PAD) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$776.4 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.7% over the period 2020-2027.

The U.S. Market is Estimated at $228.7 Million, While China is Forecast to Grow at 4.4% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$228.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 23 Featured):

• AstraZeneca Plc.
• Bayer HealthCare Pharmaceuticals
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Proteon Therapeutics, Inc.
• Sanofi S.A.
• Symic Bio, Inc.
• TheraVasc, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights
• World Market Trajectories
• PAD - A Prelude
• Recent Market Activity
• PAD Statistics
• Critical Limb Ischemia - An Insight
• High Costs - A Cause of Concern
• Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

• Aging - A Key Driver
• High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics

4. GLOBAL MARKET PERSPECTIVE

IV. COMPETITION

For more information about this report visit

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900